HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3 Autosomal Dominant Hypercholesterolemia

mutation in PCSK9
Also Known As:
Hypercholesterolemia, Autosomal Dominant, 3; FH3; HCHOLA3
Networked: 36 relevant articles (0 outcomes, 2 trials/studies)

Disease Context: Research Results

Related Diseases

1. Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
2. Neoplasms (Cancer)
3. Hyperaldosteronism (Conn Syndrome)
4. Hyperplasia
5. Familial Hyperaldosteronism

Experts

1. Geyer, Matthias: 3 articles (04/2014 - 02/2006)
2. Gomez-Sanchez, Celso E: 2 articles (12/2021 - 01/2017)
3. Fackler, Oliver T: 2 articles (09/2008 - 02/2006)
4. Schönichen, André: 2 articles (09/2008 - 02/2006)
5. Ishizaki, T: 2 articles (05/2005 - 02/2001)
6. Kitayama, Chikako: 2 articles (03/2005 - 02/2003)
7. Uyeda, Taro Q P: 2 articles (03/2005 - 02/2003)
8. Matsuda, Tadashi: 1 article (12/2021)
9. Mizuno, Yosuke: 1 article (12/2021)
10. Mukai, Kuniaki: 1 article (12/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to 3 Autosomal Dominant Hypercholesterolemia:
1. CholesterolIBA
2. Cytochrome P-450 CYP11B2 (CYP11B2)IBA
3. Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
4. ForminsIBA
5. Proteins (Proteins, Gene)FDA Link
6. GTP Phosphohydrolases (GTPases)IBA
7. Apolipoproteins B (ApoB)IBA
8. rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
9. Monoclonal AntibodiesIBA
10. AntigensIBA

Therapies and Procedures

1. Transjugular Intrahepatic Portasystemic Shunt
2. Adrenalectomy